Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pathway inhibition: emerging molecular targets for treating glioblastoma.

Pathway inhibition: emerging molecular targets for treating glioblastoma. Neuro Oncol. 2011 Jun; 13(6):566-79.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.